Work

Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]

Year: 2017

Type: erratum

Source: Neoplasia

DOI: 10.1016/j.neo.2017.10.001

Authors: Swetha Tati, John C. Fisk, Julia Abdullah, Loukia Karacosta, Taylor Chrisikos, Padraic Philbin, Susan Morey, Diala Ghazal, Fatma Zalzala, Joseph Jessee, Sally Quataert, Stephen Koury, David Moreno, Jing Ying Eng, Vladislav V. Glinsky, Olga V. Glinskii, Muctarr Sesay, Anthony W. Gebhard, Karamverr Birthare, James R. Olson, Kate Rittenhouse-Olson

Institutions: University at Buffalo, State University of New York, For Robin (United States), Harry S. Truman Memorial Veterans' Hospital, University of Missouri, ProgenaBiome (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,530

Funder: National Cancer Institute

Awards: Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy, Clinical Translation of an Anti-Metastatic Antibody for Breast Cancer Therapy

OpenAlex ID: W2779227187

Cites:

Cited by: 2

Related to: 10